Higher ALT levels before treatment in patients with hepatitis B, as markers of increased inflammatory activity for liver necrosis, was related to the worse clinical outcomes, which suggested that biochemical response might be also important for the ascites re-compensation after NUC therapy in HBV-associated decompensated cirrhosis of ascites. This evidence concerns the gene GPT and Cirrhosis.